Gonadorelin is a gonadotropin-releasing hormone agonist (GnRH agonist) which is used in fertility medicine and to treat amenorrhea and hypogonadism. It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pituitary.
This report contains market size and forecasts of Gonadorelin in global, including the following market information:
Global Gonadorelin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gonadorelin Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Gonadorelin companies in 2021 (%)
The global Gonadorelin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nasal Spray Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gonadorelin include Merck, Zoetis, Ferring Pharmaceuticals, Hemmo Pharmaceuticals, Laboratorios Syva and Shanghai Soho-Yiming Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gonadorelin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gonadorelin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Gonadorelin Market Segment Percentages, by Type, 2021 (%)
Nasal Spray
Injection
Global Gonadorelin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Gonadorelin Market Segment Percentages, by Application, 2021 (%)
Humans
Other Mammals
Global Gonadorelin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Gonadorelin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gonadorelin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gonadorelin revenues share in global market, 2021 (%)
Key companies Gonadorelin sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Gonadorelin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Zoetis
Ferring Pharmaceuticals
Hemmo Pharmaceuticals
Laboratorios Syva
Shanghai Soho-Yiming Pharmaceuticals